Microcrystalline tyrosine as a novel depot-forming agent in venom immunotherapy: a pre-clinical evaluation in bee-venom allergic mice
{{output}}
Background: Venom immunotherapy (VIT) with aqueous venom extracts is a standard treatment for severe insect venom allergies. In other fields of allergen immunotherapy (AIT), depot adjuvants have been used for decades, with benefi... ...
